Clinical Trial Detail

NCT ID NCT03915379
Title A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

JNJ-67571244

Age Groups: adult senior

No variant requirements are available.